Genenta Science S.p.A.
GNTA
Rank in Stocks
#27458
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
Share Price
$0.6851
Last synced: 2026-11-10
Market Cap
$14.54M
Change (1 day)
0.74%
Change (1 year)
-65.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Genenta Science S.p.A. (GNTA)
Category
Healthcare
Operating Margin for Genenta Science S.p.A. (GNTA)
Operating Margin as of November 2026 TTM: -203.03%
According to Genenta Science S.p.A.'s latest financial reports, its current operating margin (TTM) is -203.03%. At the end of 2019 the company had an operating margin of -203.03%.
Operating Margin history for Genenta Science S.p.A. from 2011 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -203.03% | 0.00% |
| 2019 | -203.03% | -96.67% |
| 2018 | -6,099.97% | 755.44% |
| 2017 | -713.08% | 672.57% |
| 2016 | -92.30% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -195.39% | -99.04% |
US
|
|
| 33.87% | -100.17% |
US
|
|
| -116.04% | -99.43% |
US
|
|
| 25.57% | -100.13% |
AU
|
|
| 31.23% | -100.15% |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Genenta Science S.p.A.'s operating margin
What is Genenta Science S.p.A.'s operating margin?
Genenta Science S.p.A.'s operating margin is -203.03%, as of Nov 2026.
What was Genenta Science S.p.A.'s operating margin in 2019?
In 2019, Genenta Science S.p.A.'s operating margin was -203.03%, compared with -6,099.97% in 2018.
How has Genenta Science S.p.A.'s operating margin changed since 2014?
From 2014 to 2019, Genenta Science S.p.A.'s operating margin was highest in 2015 (0.00%) and lowest in 2018 (-6,099.97%).
How does Genenta Science S.p.A.'s operating margin compare with similar companies?
Genenta Science S.p.A.'s operating margin (-203.03%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.